加载中
NASDAQHealthcareMedical - Diagnostics & Research
最新数据
US$267.76
−US$5.78 · -2.11%
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
前收盘价
US$267.76
−US$5.78 · -2.11%
盘前
US$264.99
−US$2.77 · -1.03%
10月8日 8:21 ET
盘中时间采用ET。市场数据可能有所延迟。
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
日内区间
当前US$267.76
52周区间
当前US$267.76
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
买入
估值
84
深度低估
情绪
54
多空交织
风险
38
中等风险
动量
72
动能增强
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
日内区间
当前US$267.76
52周区间
当前US$267.76
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 43.38亿 USD | 43.72亿 USD | 45.04亿 USD | 45.84亿 USD | 45.26亿 USD |
| 销货成本 | 14.45亿 USD | 15.11亿 USD | 17.6亿 USD | 16.12亿 USD | 13.72亿 USD |
| 毛利 | 28.93亿 USD | 28.61亿 USD | 27.44亿 USD | 29.72亿 USD | 31.54亿 USD |
| 研究与开发 | 9.51亿 USD | 11.69亿 USD | 13.54亿 USD | 13.21亿 USD | 11.85亿 USD |
| 销售、一般及管理费用 | 10.78亿 USD | 10.92亿 USD | 16.12亿 USD | 12.97亿 USD | 20.92亿 USD |
| 营业费用 | 20.29亿 USD | 36.94亿 USD | 38.13亿 USD | 71.51亿 USD | 32.77亿 USD |
| 利息收入 | 4000万 USD | 4600万 USD | 5800万 USD | 1100万 USD | — |
| 利息支出 | 1.01亿 USD | 1亿 USD | 7700万 USD | 2600万 USD | 6100万 USD |
| 折旧和摊销 | 2.7亿 USD | 3.54亿 USD | 4.32亿 USD | 3.94亿 USD | 2.51亿 USD |
| 营业利润 | 8.64亿 USD | −8.33亿 USD | −10.69亿 USD | −41.79亿 USD | −1.23亿 USD |
| 净利润 | 8.5亿 USD | −12.23亿 USD | −11.61亿 USD | −44.04亿 USD | 7.62亿 USD |
公司数据更新于 2026年10月8日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$241
下跌空间 9.99%| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2008年9月23日 | 2:1 | — | — |
已生效 2008年9月23日
2:1
报告持有此股票敞口的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T794.17亿0.06%129.41万亿 JPY0.09%JP¥122,700-0.57%
Vanguard Morningstar Total Stock Market ETFVTI9.76亿0.04%2.3万亿 USD0.03%US$381.03-0.40%
Vanguard Morningstar Small-Cap ETFVB7.07亿0.38%1853亿 USD0.03%US$286.98-1.41%
iShares Core S&P 500 ETFIVV5.5亿0.06%8996.25亿 USD0.03%US$780.58-0.25%
State Street SPDR S&P 500 ETFSPY5.02亿0.06%8190.39亿 USD0.09%US$777.22-0.24%
Vanguard Extended Market ETFVXF3.75亿0.39%954亿 USD0.05%US$233.49-1.56%
iShares Biotechnology ETFIBB3.12亿3.00%104.01亿 USD0.44%US$203.34+0.12%
State Street Health Care Select Sector SPDR ETFXLV2.94亿0.68%431.09亿 USD0.08%US$168.81+1.03%State Street SPDR S&P 500 ETF1557.TVanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBiShares Core S&P 500 ETFIVVState Street SPDR S&P 500 ETFSPYVanguard Extended Market ETFVXFiShares Biotechnology ETFIBBState Street Health Care Select Sector SPDR ETFXLVAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
